Search results
Results from the WOW.Com Content Network
The management of Tourette syndrome has the goal of managing symptoms to achieve optimum functioning, rather than eliminating symptoms; not all persons with Tourette's require treatment, and there is no cure [1] or universally effective medication. [2]
Tourette syndrome or Tourette's syndrome (abbreviated as TS or Tourette's) is a common neurodevelopmental disorder that begins in childhood or adolescence. It is characterized by multiple movement (motor) tics and at least one vocal (phonic) tic. Common tics are blinking, coughing, throat clearing, sniffing, and facial movements.
Ecopipam (development codes SCH-39166, EBS-101, and PSYRX-101) is a dopamine antagonist which is under development for the treatment of Lesch-Nyhan syndrome, Tourette syndrome, speech disorders, and restless legs syndrome. [1] It is taken by mouth. [2] Ecopipam acts as a selective dopamine D 1 and D 5 receptor antagonist. [1]
Comprehensive Behavioral Intervention for Tics (CBIT), based on HRT, is a first-line treatment for Tourette syndrome and tic disorders. [10] [11] With a high level of confidence, CBIT has been shown to be more likely to lead to a reduction in tics than other supportive therapies or psychoeducation. [12]
The Tourette Association of America (TAA), based in Bayside, New York, United States, is a non-profit voluntary organization and the only US health-related organization serving people with Tourette syndrome. It was founded in 1972 as the Tourette Syndrome Association (TSA), later changing its name.
Robertson's research explored Tourette syndrome; [1] [5] she authored or co-authored over 200 peer-reviewed articles and four books. In 2000 she co-founded in Denmark with Anne Korsgaad the European Society for the Study of Tourette Syndrome (ESSTS), of which she was appointed Honorary President for Life in 2008.
Related: Baylen Dupree’s Siblings Open Up About How Her Tourette Syndrome Has 'Put a Strain' on Relationship with Their Parents While she can't mute the ongoings of an airport, she can manage ...
DBS has been used experimentally in treating adults with severe Tourette syndrome who do not respond to conventional treatment. Despite widely publicized early successes, DBS remains a highly experimental procedure for treating Tourette's, and more study is needed to determine whether long-term benefits outweigh the risks.